STRYKER CORPORATION for STRYKER CORPORATION
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
S. 232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax on medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax on medical devices
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAGE KRANBUHL | Senate HELP Subcommittee staff |
Health Issues HCR
Implementation of Public Law 112-144: The Food and Drug Administration Safety and Improvement Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAGE KRANBUHL | Senate HELP Subcommittee staff |
Trade (domestic/foreign) TRD
Korea Free Trade Agreement Implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC RUGO | — |
Budget/Appropriations BUD
Funding for the FDA Center for Devices and Radiological Health
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAGE KRANBUHL | Senate HELP Subcommittee staff |
Medicare/Medicaid MMM
Implementation of Public Law 111-148: The Patient Protection and Affordable Care Act, particularly accountable care organizations and bundled payment models
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAGE KRANBUHL | Senate HELP Subcommitee staff |
| ERIC RUGO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.